IDH1 and glioblastoma: Fifteen (93.8%) patients' tumors were diagnosed as glioblastoma (GBM) on histopathology (one patient had anaplastic astrocytoma), 13 (86.7%) were IDH1 wild-type and 2 (13.3%) were IDH1 mutants.